| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |